哈佛大学惊人发现：新冠对人类未来影响巨大！
近日，哈佛大学公共卫生学院发了一篇 Science：根据论文中的描述，无论是否能研发出疫苗，新冠病毒都可能会陪伴人类到2025年。
https://mp.weixin.qq.com/s/cV1XNI0-p5Z-g7lBkmj3nQ
https://mp.weixin.qq.com/s/cV1XNI0-p5Z-g7lBkmj3nQ
Past 31 days
Total Visit: 0
Pei-Chi Lo mark this message contains misinformation
｜originally written by Pei-Chi Lo
■所提的科學研究皆存在，但部分詮釋有誤，例如；
①《Science》的確有刊出哈佛學者Stephen M. Kissler等人的研究，但文中並未提及其認為疫苗開發出來後作用會很小；其僅說在現況下，因為疫苗與藥物仍須長時間開發，因此非藥物介入是目前唯一能馬上遏止傳播的方式。
論文中也沒有提到「預期壽命降低」這類的論述。
②《自然醫學》的確刊登重慶醫科大學團隊的論文，但該論文並沒有針對「出院後抗體水平」進行研究或分析。
③《Cell》Bette Korber等人的論文的確認為D614G的突變增加COVID-19病毒傳染性；但Nathan D. Grubaugh等人的論文回應則認為此單一突變在差異性大的大眾群體中尚無法認為會產生重大改變，D614G對疫情的影響仍不明確(Remains Unclear)。
■至於對未來社會變化的預測(NBA收入結構將變化等)僅屬個人觀點，與科學研究無任何關聯。
①《Science》的確有刊出哈佛學者Stephen M. Kissler等人的研究，但文中並未提及其認為疫苗開發出來後作用會很小；其僅說在現況下，因為疫苗與藥物仍須長時間開發，因此非藥物介入是目前唯一能馬上遏止傳播的方式。
論文中也沒有提到「預期壽命降低」這類的論述。
②《自然醫學》的確刊登重慶醫科大學團隊的論文，但該論文並沒有針對「出院後抗體水平」進行研究或分析。
③《Cell》Bette Korber等人的論文的確認為D614G的突變增加COVID-19病毒傳染性；但Nathan D. Grubaugh等人的論文回應則認為此單一突變在差異性大的大眾群體中尚無法認為會產生重大改變，D614G對疫情的影響仍不明確(Remains Unclear)。
■至於對未來社會變化的預測(NBA收入結構將變化等)僅屬個人觀點，與科學研究無任何關聯。
References
【所提及的論文原始全文】Science-Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period：
https://science.sciencemag.org/content/368/6493/860
Nature Medicine-Antibody responses to SARS-CoV-2 in COVID-19 patients：
https://www.nature.com/articles/s41591-020-0897-1
WHO科學簡報-"Immunity passports" in the context of COVID-19：
https://www.who.int/news-room/commentaries/detail/immunity-passports-in-the-context-of-covid-19
Cell-Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332439/
Cell-Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332445/
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
Four months into the severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) outbreak, we still do not know enough about postrecovery immune protection and environmental and seasonal influences o
Antibody responses to SARS-CoV-2 in patients with COVID-19
A cross-sectional study of hospitalized patients with COVID-19 and a longitudinal follow-up study of patients with COVID-19 suggest that SARS-CoV2-specific IgG or IgM seroconversion occurs within 20 d
Cannot get data from URL
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
A SARS-CoV-2 variant carrying the Spike protein amino acid change D614G has become the most prevalent form in the global pandemic. Dynamic tracking of variant frequencies revealed a recurrent pattern
Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear
In this issue of Cell, Korber et al. found that a SARS-CoV-2 variant in the spike protein D614G rapidly became dominant around the world. Although clinical and in vitro data suggest that D614G changes
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.
查謠言詐騙